Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress, demonstrating that frontline maintenance therapy combining Imdelltra (tarlatamab-dlle)and Imfinzi (durvalumab) cut the risk of...
India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing...
Food and Drug Administration (FDA) for JUVMO™ (tavapadon) to treat adult patients living with Parkinson’s disease. JUVMO represents a first-of-its-kind therapeutic approach, utilizing a...
Sun Pharmaceutical Industries Limited and LIB Therapeutics Inc. announced an exclusive global licensing, manufacturing, and commercialization agreement for lerodalcibep across international markets, excluding the United...
Bharat Technology's national conference, BT-PHARMACON 2K26, was held bringing together eminent personalities from the State Government, the Pharmacy Council of India (PCI), academia, and...
At the five-year evaluation mark, half of the treated patients (50%) remained alive and progression-free. The trial demonstrated a notable five-year overall survival rate...
Addressing BT-PHARMACON 2K26, organized by Bharat Technology at EZCC, Kolkata, Pharmacy Council of India (PCI) President Dr. Montu M. Patel emphasized the need for...